'Iv administration' presentation slideshows

Drugs for Coagulation disorders

Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet agents III. Thrombolytics . I. Anticoagulants A. The coagulation cascade.

967 views • 74 slides

Drugs & Chemicals Poisoning

Drugs & Chemicals Poisoning By Dr. Jamshidi. Management of overdose and poisoning . General- evaluation. Rcognition of poisoning Identification of agents involved Assessment of severity Prediction of toxicity .

1.05k views • 59 slides

Preventing Medication Errors in Pediatric and Neonatal Patients

Preventing Medication Errors in Pediatric and Neonatal Patients. Learning Objectives. Discuss common medication errors that occur in pediatric and neonatal patient care Describe error reduction strategies for the pediatric and neonatal populations

1.03k views • 55 slides

Nutrition in Patients with Gastrointestinal Disorder

Nutrition in Patients with Gastrointestinal Disorder. The major organs of digestion are those within the gastrointestinal tract (GIT), which begins with the mouth and ends with the anus. The accessory organs or digestion include the liver, gallbladder and pancreas.

659 views • 45 slides

METHODS OF DETERMINING ABSORPTION RATE CONSTANT

A SEMINAR ON. METHODS OF DETERMINING ABSORPTION RATE CONSTANT. by V. Sandeep Kumar M.Pharmacy, I Sem. Department of Pharmaceutics University College Of Pharmaceutical Sciences Kakatiya University Warangal. CONTENTS. Introduction Methods To Detect Absorption Rate Constant.

16.64k views • 42 slides

RADIOPHARMACY

760 views • 30 slides

Local Improvement Clinic A2

Dr Don Berwick President & CEO, IHI Dr Ross Wilson Chair, Strategic Advisory Board International Forum Ms Nellie Yeo CQO, National Healthcare Group, Singapore. Local Improvement Clinic A2. Project to reduce complications after cardiac catheterisation.

482 views • 26 slides

Respiratory Distress Syndrome

Respiratory Distress Syndrome. By Dr. Nahed Al- Nagger. Learning Objectives. Define RDS or HMD. List the causes of Respiratory Distress Syndrome (RDS). State the predisposing factors. Discuss pathophysiology of hyaline membrane disease (HMD). Learning Objectives.

823 views • 25 slides

AMA 116 IV Theory

AMA 116 IV Theory. Objectives of IV Therapy:. Restore and maintain fluid and electrolyte balance Provide medications and chemotherapy Transfuse blood and blood products Deliver parenteral nutrients and nutritional supplements. Benefits of IV Therapy:. Allows more accurate dosing

255 views • 25 slides

College of Nursing Adult Health Nursing II Block 7.0

College of Nursing Adult Health Nursing II Block 7.0. Topic: IV Medication Administration Module: 1.2. IV Medication Administration. Block 7.0 Adult Health II. Learning Outcomes. Apply the principles of safe intravenous medication administration.

400 views • 22 slides

Figure 1

Figure 1.

295 views • 16 slides

Diseases Acquired through the alimentary route

Diseases Acquired through the alimentary route. Botulism Hemorrhagic colitis (Escherichia Coli 0157:H7). Clostridium botulinum. Gram-positive bacteria Rod shaped Most commonly found in the soil Spore forming Strict anaerobe Heat sensitive Prefers low acidic environment. Botulism.

307 views • 15 slides

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez. Diseases of Mineral and Bone. Hypercalcemia. Blood calcium levels above expected range Causes of: Malignancy Primary Hyperparathyroidism Renal Failure Multiple myeloma. Clinical Symptoms of Hypercalcemia. CNS Disorientation Lethargy

346 views • 15 slides

Lyme Disease

222 views • 10 slides

Moreau P et al. Proc ASH 2010 ; Abstract 312.

A Phase 3 Prospective, Randomized, International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma. Moreau P et al. Proc ASH 2010 ; Abstract 312. Phase III Multicenter Trial Schema. Subcutaneous (SC)

200 views • 8 slides

Needle-free IV Connectors Market Set to Encounter Paramount Growth to 2025

The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).

51 views • 4 slides

Lite Bites of learning for improving medicines safety

154 views • 1 slides

INTRAVENOUS TREATMENT

Modern world is the world of challenges, risks, development, and approaches.When the concern is about the treatment of severe and life threatening diseases

96 views • 1 slides